Marksans Pharma - Unaudited Financial Results for Sep 30, 2008
Marksans Pharma Ltd has informed BSE about the Standalone & Consolidated unaudited financial results for the Quarter ended Sep 30, 2008.01-11-2008
01-11-2008
Marksans Pharma - Outcome of AGM
Marksans Pharma Ltd has informed BSE that the members at the 16th Annual General Meeting (AGM) of the Company held on September 29, 2008, inter alia, have passed the following resolutions: 1. Adoption of Audited Annual Accounts for the Financial year ended March 31, 2008.2. Appointment of Mr. M B Parikh, as Director, retiring by rotation....29-09-2008
Marksans Pharma - Outcome of Board Meeting
Marksans Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 23, 2008, inter alia, has decided to make allotment of 8400241 Equity shares of Re 1/- to M/s. Bamacle LLC on preferential allotment basis.23-09-2008
Marksans Pharma - Postponement of Board Meeting
With reference to earlier annoucement dated September 08, 2008 regarding Board Meeting on Sep 16, 2008, Marksans Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company scheduled to be held on September 16, 2008, inter alia, to make allotment of 8400241 Equity Shares of Rs 1/- to M/s. Bamacle LLc on Preferential allotment basis, has been postponed to be held on September 23, 2008, at the same time and same place to transact the same agenda.15-09-2008
Marksans Pharma fixes Book Closure for AGM
Marksans Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 25, 2008 to September 29, 2008 for the purpose of Annual General Meeting (AGM) of the Company to be held on September 29, 2008.11-09-2008
Marksans Pharma - Outcome of EGM
Marksans Pharma Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on September 10, 2008, have approved the Special Resolution under Section 81(1)(A) of the Companies Act, 1956 for allotment of 8400241 Equity Shares of Re 1/- each, of the Company to M/s. Barnacle LLC on preferential allotment basis.10-09-2008
Marksans Pharma - Board Meeting on Sep 16, 2008
Marksans Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on September 16, 2008, to make allotment of 8400241 Equity shares of Re 1/- to M/s. Bamacle LLc on preferential allotment basis, if approved by the shareholders at the Extra Ordinary General Meeting to be held on September 10, 2008.08-09-2008
Marksans Pharma - Outcome of Board Meeting
Marksans Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 02, 2008, inter alia, has taken following decisions:1. Appointment of Statutory Auditors of the Company subject to the approval of the members of the Company.2. Approval of ESOP scheme for the employees of the Company....02-09-2008
Marksans Pharma - Outcome of Board Meeting
Marksans Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 27, 2008 has decided to acquire entire shareholding of M/s. Relonchem Ltd.28-08-2008
Marksans Pharma - Press Release
Marksans Pharma Ltd has informed BSE regarding a Press Release dated August 27, 2008 titled "Marksans Pharma acquires UK's leading generic pharma company Relonchem Ltd"Press Release:- The acquisition will help Marksans Pharma make deep and Immediate Inroads in the high growth, regulated UK generic licensing market of wholesalers, retailers and hospitals....28-08-2008